Northwest Biotherapeutics (NWBO) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Northwest Biotherapeutics (NWBO) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 73.00% |
| 10 | Northwest Biotherapeutics | 272.75 Mn | 270.97 Mn | - | 57.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.00% |
| Dec 31, 2025 | -115.26% |
| Sep 30, 2025 | 23.22% |
| Jun 30, 2025 | 85.57% |
| Mar 31, 2025 | -4.19% |
| Dec 31, 2024 | -149.84% |
| Sep 30, 2024 | 12.50% |
| Jun 30, 2024 | 1.49% |
| Mar 31, 2024 | 17.84% |
| Dec 31, 2023 | 133.49% |
| Sep 30, 2023 | -5,868.15% |
| Jun 30, 2023 | 29.23% |
| Mar 31, 2023 | -95.52% |
| Dec 31, 2022 | -54.83% |
| Sep 30, 2022 | 97.83% |
| Jun 30, 2022 | 4.16% |
| Mar 31, 2022 | 52.26% |
| Dec 31, 2021 | -217.09% |
| Sep 30, 2021 | 27.51% |
| Jun 30, 2021 | -124.41% |